AI-generated summary
The authors retrospectively reviewed six patients with early-stage mycosis fungoides treated with a 308-nm excimer laser. They report the laser was safe and well tolerated, and four patients (66%) improved, with three complete responses and one partial response. The study is limited by its small, retrospective design, and the authors call for a larger prospective study.
- Participants
- 6
- Who or what was studied
- Six consecutive patients with refractory stage IA to IIA mycosis fungoides
- Wavelengths
- 308 nm
- Limits stated in the abstract
- Retrospective study of only 6 patients, and the authors state a prospective study with a larger sample size would be desirable.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Ultraviolet, Phototherapy, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.